{
  "ptid_time": "041_S_4138_2011-10-21",
  "img_path": "/data/qiuhui/data/adni/images/041_S_4138/2011-10-21/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 4,724 mm³, 27.3% below the reference mean. With a Z-score of -2.19 (1.4th percentile), this represents significant atrophy; whole brain volume measures 874,033 mm³, 5.8% below the reference mean. With a Z-score of -0.70 (24.2th percentile), this represents normal volume . ",
  "text_data": "Age is 88.4 years. Gender is Female. Education: 14 years. Handedness: Left. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Major Surgical Procedures. MMSE: 26.0. MoCA: 20.0. Logical Memory: 1.0. Laboratory findings: Lymphocytes: 3.19 (significant elevated); Serum Glucose: 160.00 (profound elevated); Triglycerides (GPO): 295.00 (profound elevated); AST (SGOT): 14.00 (significant reduced). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.03 SUVR (normal ); Total tau: 359.50 pg/mL (moderate elevated); Phosphorylated tau: 33.03 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows significant atrophy (Z-score -2.19, 1.4th percentile), which is strongly associated with Alzheimer's pathology, while whole brain volume is within normal limits. The MoCA score of 20 suggests cognitive impairment, and the moderately elevated T-tau and P-tau levels further support neurodegenerative changes, despite normal AV45 (amyloid PET).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology, given biomarker profile).  \n\n**Confidence:** **Medium** (while hippocampal atrophy and tau elevation strongly suggest early Alzheimer's, the normal amyloid PET and absence of APOE4 introduce some uncertainty).",
  "timestamp": "2025-07-26T07:12:48.666952"
}